ALT - CIK 0001326190
The table below shows Altimmune, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $97.60M | $61.24M | $183.10M | $49.10M | $31.47M | $57.13M |
| Short-term investments | $233.94M | $149.54M | $94.97M | $100.72M | $107.91M | $107.78M |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $334.68M |
| $216.62M |
| $188.42M |
| $155.26M |
| $145.76M |
| $171.19M |
| Property, plant & equipment | $208.00K | $337.00K | $364.00K | $384.00K | $446.00K | $483.00K |
| Goodwill | - | - | - | - | - | - |
| Total assets | $335.63M | $218.45M | $190.35M | $157.26M | $147.86M | $173.35M |
| Accounts payable | $1.53M | $4.80M | $851.00K | $1.08M | $1.13M | $2.69M |
| Total current liabilities | $11.32M | $12.61M | $9.22M | $9.80M | $8.64M | $15.15M |
| Long-term debt | $34.51M | $14.45M | $14.33M | - | - | - |
| Total liabilities | $51.64M | $32.85M | $28.98M | $15.10M | $14.49M | $20.82M |
| Retained earnings | -$672.05M | -$622.13M | -$603.11M | -$580.97M | -$538.21M | -$515.37M |
| Total equity | $283.99M | $185.60M | $161.37M | $142.16M | $133.38M | $152.53M |